Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,448 | 28 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $576.99 | 12 | $0 (2024) |
| Aurinia Pharma U.S., Inc. | $252.15 | 3 | $0 (2024) |
| NxStage Medical, Inc. | $161.83 | 2 | $0 (2023) |
| Calliditas Therapeutics US Inc. | $146.52 | 2 | $0 (2023) |
| Ardelyx, Inc. | $125.00 | 1 | $0 (2024) |
| Amgen Inc. | $65.96 | 2 | $0 (2022) |
| Alexion Pharmaceuticals, Inc. | $41.30 | 2 | $0 (2020) |
| Horizon Therapeutics plc | $40.50 | 2 | $0 (2023) |
| Fresenius USA Marketing, Inc. | $24.26 | 1 | $0 (2023) |
| GlaxoSmithKline, LLC. | $13.24 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $331.95 | 3 | Ardelyx, Inc. ($125.00) |
| 2023 | $657.29 | 13 | AstraZeneca Pharmaceuticals LP ($302.57) |
| 2022 | $350.80 | 8 | AstraZeneca Pharmaceuticals LP ($181.50) |
| 2020 | $107.71 | 4 | Alexion Pharmaceuticals, Inc. ($41.30) |
All Payment Transactions
28 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/10/2024 | Ardelyx, Inc. | XPHOZAH 30 MG (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: NEPHROLOGY | ||||||
| 04/23/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $114.03 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 03/14/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $92.92 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/19/2023 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $24.26 | General |
| Category: Phosphate binder for ESRD | ||||||
| 11/10/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: RESPIRATORY | ||||||
| 10/25/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $124.96 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/19/2023 | Calliditas Therapeutics US Inc. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Nephrology | ||||||
| 10/12/2023 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/19/2023 | NxStage Medical, Inc. | PUREFLOW SL (Device), NXSTAGE SYSTEM ONE | Food and Beverage | In-kind items and services | $130.20 | General |
| Category: Nephrology | ||||||
| 03/13/2023 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/08/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/28/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $20.57 | General |
| Category: KRYSTEXXA | ||||||
| 02/15/2023 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/03/2023 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/19/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: KRYSTEXXA | ||||||
| 01/06/2023 | Calliditas Therapeutics US Inc. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $21.52 | General |
| Category: Nephrology | ||||||
| 11/16/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.82 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/21/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.82 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/15/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $1.73 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/14/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.17 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/22/2022 | Amgen Inc. | Parsabiv (Drug) | Food and Beverage | In-kind items and services | $31.18 | General |
| Category: Nephrology | ||||||
| 06/30/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $114.96 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/24/2022 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $30.00 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 05/25/2022 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $108.12 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 10/06/2020 | Alexion Pharmaceuticals, Inc. | Ultomiris (Drug) | Food and Beverage | In-kind items and services | $28.32 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 296 | 668 | $281,575 | $67,532 |
| 2022 | 6 | 239 | 601 | $194,814 | $42,959 |
| 2021 | 4 | 136 | 281 | $77,271 | $17,788 |
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 88 | 294 | $81,149 | $19,546 | 24.1% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 13 | 50 | $54,500 | $14,719 | 27.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 39 | 94 | $39,574 | $9,815 | 24.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 31 | 72 | $28,584 | $7,261 | 25.4% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 12 | 24 | $22,008 | $5,935 | 27.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 29 | 30 | $18,861 | $3,319 | 17.6% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 41 | 44 | $19,492 | $3,099 | 15.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 17 | 17 | $10,914 | $2,059 | 18.9% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 26 | 43 | $6,493 | $1,779 | 27.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 99 | 344 | $94,792 | $20,911 | 22.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 49 | 145 | $57,565 | $12,735 | 22.1% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 38 | 38 | $16,579 | $3,166 | 19.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 18 | 29 | $12,209 | $3,097 | 25.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 14 | 14 | $8,988 | $2,036 | 22.7% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 21 | 31 | $4,681 | $1,014 | 21.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 57 | 148 | $40,848 | $9,307 | 22.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 32 | 32 | $15,268 | $3,769 | 24.7% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 34 | 77 | $11,627 | $2,574 | 22.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 13 | 24 | $9,528 | $2,137 | 22.4% |
About Dr. Jennifer Griffiths, M.D
Dr. Jennifer Griffiths, M.D is a Internal Medicine healthcare provider based in Valhalla, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/06/2016. The National Provider Identifier (NPI) number assigned to this provider is 1942656053.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jennifer Griffiths, M.D has received a total of $1,448 in payments from pharmaceutical and medical device companies, with $331.95 received in 2024. These payments were reported across 28 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($1,448).
As a Medicare-enrolled provider, Griffiths has provided services to 671 Medicare beneficiaries, totaling 1,550 services with total Medicare billing of $128,279. Data is available for 3 years (2021–2023), covering 19 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Valhalla, NY
- Active Since 05/06/2016
- Last Updated 11/29/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1942656053
Products in Payments
- FARXIGA (Drug) $499.38
- LUPKYNIS (Drug) $252.15
- TARPEYO (Drug) $146.52
- PUREFLOW SL (Device) $130.20
- XPHOZAH 30 MG (Drug) $125.00
- LOKELMA (Drug) $77.61
- Parsabiv (Drug) $65.96
- Ultomiris (Drug) $41.30
- KRYSTEXXA (Biological) $40.50
- SYSTEM ONE (Device) $31.63
- Velphoro (Drug) $24.26
- TRELEGY ELLIPTA (Drug) $13.24
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Valhalla
Dr. Jay Doshi, M.d, M.D
Internal Medicine — Payments: $96,684
Luciano De Marco, M.d, M.D
Internal Medicine — Payments: $14,149
Neal Shah, M.d, M.D
Internal Medicine — Payments: $5,403
Sade Solola Nussbaum, Md, MD
Internal Medicine — Payments: $4,024
Rhonda Rubin, Md, MD
Internal Medicine — Payments: $2,982
Adrese Kandahari, M.d, M.D
Internal Medicine — Payments: $2,880